Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The scope of the agreement... Read more
Bangalore: US-based Pfenex and India-based Agila Biotech, a subsidiary of Strides Arcolab, entered into a joint venture (JV)... Read more
Singapore: Seoul-based Samsung Bioepis and MSD, known as Merck in the US and Canada, have entered into an agreement to develop... Read more
Bangalore: Biocon has announced positive results from a phase I comparative study conducted in Germany of its biosimilar insulin glargine... Read more
With the suspension of the registration of 36 similar bio-therapeutic products in Sri Lanka, the country's healthcare market has become... Read more
At the recently concluded BIO Boston 2012, India reiterated its commitment to providing a conducive policy environment for the development... Read more
Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets... Read more
India-headquartered Dr Reddy's Laboratories is making a strong name in biosimilars business in India and in the world. In 2011, the company... Read more
Singapore: Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have entered into a partnership to co-develop... Read more
The much-anticipated draft guidance on biosimilars product development issued by US Food and Drug Administration (FDA) gives a direction... Read more
The year 2012 has brought a world of opportunities for Indian biotech companies, with big-wig biotech firms in the West facing a spree of... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
